Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Acurx Pharmaceuticals (ACXP) Institutional Ownership

Acurx Pharmaceuticals logo
$1.93 +0.04 (+2.12%)
Closing price 04:00 PM Eastern
Extended Trading
$1.94 +0.01 (+0.52%)
As of 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Acurx Pharmaceuticals (NASDAQ:ACXP)

Current
Institutional Ownership
Percentage
11.53%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$11.79M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$1.53M
Get ACXP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acurx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ACXP Institutional Buying and Selling by Quarter

Acurx Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/24/2026 Prospect Financial Services LLC13,785$51K0.0%-30.5%0.482%
2/18/2026 Millennium Management LLC41,427$103K0.0%N/A1.625%
2/12/2026 Jane Street Group LLC10,743$27K0.0%N/A0.422%
2/9/2026 Geode Capital Management LLC12,417$31K0.0%N/A0.488%
11/17/2025 Susquehanna International Group LLP16,815$72K0.0%-75.9%0.806%
11/14/2025 Sabby Management LLC8,705$37K0.0%-89.4%0.418%
8/14/2025 Armistice Capital LLC1,078,540$551K0.0%N/A70.126%
8/8/2025 Prospect Financial Services LLC296,776$152K0.1%-19.0%19.296%
8/8/2025 Geode Capital Management LLC146,404$75K0.0%-14.6%9.519%
8/6/2025 O Brien Greene & Co. Inc60,000$31K0.0%N/A0.195%
4/11/2025Vanguard Capital Wealth Advisors67,500$26K0.0%N/A0.301%
4/11/2025Prospect Financial Services LLC366,576$143K0.1%+11.4%1.637%
1/22/2025Prospect Financial Services LLC329,076$268K0.1%+11.5%1.932%
11/16/2024Geode Capital Management LLC146,500$278K0.0%+12.7%0.902%
10/15/2024Prospect Financial Services LLC295,075$561K0.3%+6.1%1.862%
7/15/2024Prospect Financial Services LLC278,100$626K0.5%+1.9%1.756%
4/23/2024Prospect Financial Services LLC272,850$668K0.6%+6.9%1.732%
4/5/2024NBC Securities Inc.14,000$34K0.0%N/A0.089%
2/20/2024Prospect Financial Services LLC255,150$977K1.0%N/A1.853%
2/1/2024Sigma Planning Corp10,000$38K0.0%N/A0.073%
11/15/2023Armistice Capital LLC500,000$750K0.0%-57.7%3.843%
8/14/2023One68 Global Capital LLC13,044$35K0.2%N/A0.101%
11/14/2022Armistice Capital LLC1,066,000$3.20M0.1%N/A9.224%
8/12/2022Semmax Financial Advisors Inc.5,879$28K0.0%+365.5%0.057%
8/1/2022Castle Wealth Management LLC13,000$49K0.0%N/A0.127%


ACXP Institutional Ownership - Frequently Asked Questions

During the previous two years, 9 institutional investors and hedge funds held shares of Acurx Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($551K), Millennium Management LLC ($103K), Susquehanna International Group LLP ($72K), Prospect Financial Services LLC ($51K), Sabby Management LLC ($37K), Geode Capital Management LLC ($31K), and O Brien Greene & Co. Inc ($31K).Learn more on Acurx Pharmaceuticals' institutional investors.

11.53% of Acurx Pharmaceuticals' stock is owned by institutional investors. Learn more on ACXP's institutional investor holdings.

The following institutional investors have purchased Acurx Pharmaceuticals' stock in the last 24 months: Armistice Capital LLC ($1.08M), Prospect Financial Services LLC ($93.73K), Vanguard Capital Wealth Advisors ($67.50K), O Brien Greene & Co. Inc ($60K), Millennium Management LLC ($41.43K), Geode Capital Management LLC ($28.90K), and Jane Street Group LLC ($10.74K).

Institutional investors have bought a total of 1,203,127 shares in the last 24 months. This purchase volume represents approximately $11.79M in transactions.

The following institutional investors have sold Acurx Pharmaceuticals stock in the last 24 months: Prospect Financial Services LLC ($75.85K), Sabby Management LLC ($73.19K), Susquehanna International Group LLP ($52.93K), and Geode Capital Management LLC ($25.08K).

Institutional investors have sold a total of 227,048 shares in the last 24 months. This volume of shares sold represents approximately $1.53M in transactions.



This page (NASDAQ:ACXP) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners